Perrigo Company plc (NYSE:PRGO – Get Free Report) was the target of a significant drop in short interest during the month of November. As of November 30th, there was short interest totalling 4,020,000 shares, a drop of 19.1% from the November 15th total of 4,970,000 shares. Based on an average trading volume of 1,500,000 shares, the short-interest ratio is presently 2.7 days.
Perrigo Trading Down 0.5 %
NYSE:PRGO traded down $0.14 on Friday, reaching $27.45. The company’s stock had a trading volume of 966,639 shares, compared to its average volume of 1,601,242. The firm has a market cap of $3.74 billion, a PE ratio of -23.46 and a beta of 0.52. The company has a debt-to-equity ratio of 0.94, a quick ratio of 1.77 and a current ratio of 2.56. The business’s 50-day moving average price is $26.52 and its two-hundred day moving average price is $26.97. Perrigo has a 1-year low of $23.89 and a 1-year high of $34.60.
Perrigo (NYSE:PRGO – Get Free Report) last announced its earnings results on Wednesday, November 6th. The company reported $0.81 EPS for the quarter, hitting the consensus estimate of $0.81. Perrigo had a negative net margin of 3.64% and a positive return on equity of 7.38%. The firm had revenue of $1.09 billion for the quarter, compared to the consensus estimate of $1.12 billion. The business’s quarterly revenue was down 3.2% on a year-over-year basis. During the same period last year, the company posted $0.64 EPS. Equities research analysts anticipate that Perrigo will post 2.56 earnings per share for the current fiscal year.
Perrigo Announces Dividend
Insider Activity at Perrigo
In other Perrigo news, Director Jeffrey B. Kindler sold 17,598 shares of the company’s stock in a transaction on Monday, December 9th. The shares were sold at an average price of $28.27, for a total transaction of $497,495.46. Following the completion of the sale, the director now owns 5,409 shares in the company, valued at approximately $152,912.43. The trade was a 76.49 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 0.70% of the stock is owned by company insiders.
Hedge Funds Weigh In On Perrigo
A number of large investors have recently added to or reduced their stakes in PRGO. Venturi Wealth Management LLC acquired a new stake in shares of Perrigo in the third quarter valued at approximately $56,000. KBC Group NV increased its stake in Perrigo by 25.1% in the 3rd quarter. KBC Group NV now owns 4,517 shares of the company’s stock valued at $118,000 after buying an additional 905 shares during the last quarter. Voisard Asset Management Group Inc. lifted its position in Perrigo by 9.7% during the 3rd quarter. Voisard Asset Management Group Inc. now owns 5,100 shares of the company’s stock worth $134,000 after buying an additional 450 shares in the last quarter. Atria Investments Inc acquired a new position in shares of Perrigo during the 3rd quarter worth about $208,000. Finally, CWM LLC grew its holdings in shares of Perrigo by 877.0% in the 2nd quarter. CWM LLC now owns 8,197 shares of the company’s stock valued at $210,000 after acquiring an additional 7,358 shares in the last quarter. Institutional investors own 95.91% of the company’s stock.
Analyst Upgrades and Downgrades
A number of equities research analysts recently commented on the company. Canaccord Genuity Group reiterated a “buy” rating and issued a $42.00 price objective on shares of Perrigo in a report on Monday, September 30th. StockNews.com upgraded shares of Perrigo from a “hold” rating to a “buy” rating in a research report on Thursday, November 7th. Finally, Jefferies Financial Group reissued a “hold” rating and set a $30.00 price objective (down previously from $50.00) on shares of Perrigo in a research note on Monday, September 23rd. One analyst has rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $37.00.
Get Our Latest Report on Perrigo
About Perrigo
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.
Featured Articles
- Five stocks we like better than Perrigo
- What is a Secondary Public Offering? What Investors Need to Know
- Dave & Buster’s: Is It Time to Make Another Play on This Stock?
- What is a Death Cross in Stocks?
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Stock Splits, Do They Really Impact Investors?
- Texas Instruments: The Old-School Tech Titan Still Delivering
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.